Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports

(1) Background: There is a high burden of poor glycemic control in the Indian population with type 2 diabetes mellitus (T2DM). Currently, the use of metformin sustained-release (SR)–vildagliptin fixed-dose combination (FDC) is very low as compared to metformin immediate-release (IR)–vildagliptin FDC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chawla, Manoj, Chawla, Purvi, Jethwani, Pratap, Shah, Kiran, Reddy, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136586/
http://dx.doi.org/10.3390/clinpract13020045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136586/
http://dx.doi.org/10.3390/clinpract13020045

Ejemplares similares